卵巢癌的异质性和治疗环境
Ana C Veneziani1, Eduardo Gonzalez-Ochoa1, Husam Alqaisi1
1Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Nature reviews. Clinical oncology
|October 2, 2023
概括
卵巢癌表现出显著的异质性,影响治疗的有效性和耐药性. 了解这种多样性对于开发针对这种致命癌症的个性化疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 卵巢癌是一种复杂的疾病,具有显著的分子,细胞和解剖学异质性.
- 这种异质性导致对治疗的反应多样化,固有的和获得的耐药性以及疾病的侵袭性进展.
- 卵巢癌包括多个亚型,每个亚型都有独特的分子形状,在疾病进展和治疗过程中演变.
研究的目的:
- 审查卵巢癌的多方面的异质性.
- 概述目前对卵巢癌的治疗情况.
- 为突出卵巢癌的新兴治疗策略.
主要方法:
- 文献综述和关于卵巢癌异质性的当前研究的综合.
- 分子,细胞和微环境特征的分析.
- 评估现有和正在发展的治疗方式.
主要成果:
- 卵巢癌不是一个单一的实体,而是具有不同亚型的疾病谱.
- 瘤微环境的相互作用显著影响疾病的演变和治疗反应.
- 目前的治疗方法往往由于异质性而失败,需要个性化的方法.
结论:
- 识别和解决卵巢癌异质性对于改善患者的治疗结果至关重要.
- 个性化治疗策略对于克服耐药性和提高治疗疗效至关重要.
- 对卵巢癌分子和细胞多样性的进一步研究将指导新疗法的开发.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K


